Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Secisbp2l | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of SECISBP2L mRNA | CTD | PMID:22206623 | Secisbp2l | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of SECISBP2L mRNA | CTD | PMID:26496021 | Secisbp2l | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of SECISBP2L mRNA | CTD | PMID:32145629 | Secisbp2l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SECISBP2L mRNA | CTD | PMID:21354282 | Secisbp2l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SECISBP2L mRNA | CTD | PMID:32109520|PMID:34747641 | Secisbp2l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SECISBP2L mRNA | CTD | PMID:21570461 | Secisbp2l | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SECISBP2L mRNA | CTD | PMID:30851411 | Secisbp2l | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Secisbp2l | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Secisbp2l | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Decitabine affects the expression of SECISBP2L mRNA | CTD | PMID:23300844 | Secisbp2l | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SECISBP2L mRNA | CTD | PMID:24780913 | Secisbp2l | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of SECISBP2L mRNA | CTD | PMID:31881176 | Secisbp2l | Rat | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of SECISBP2L protein | CTD | PMID:33236894 | Secisbp2l | Rat | all-trans-retinoic acid | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SECISBP2L mRNA | CTD | PMID:33167477 | Secisbp2l | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of SECISBP2L mRNA | CTD | PMID:38685447 | Secisbp2l | Rat | arsenite(3-) | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SECISBP2L mRNA] | CTD | PMID:32406909 | Secisbp2l | Rat | beta-lapachone | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of SECISBP2L mRNA | CTD | PMID:38218311 | Secisbp2l | Rat | beta-lapachone | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of SECISBP2L mRNA | CTD | PMID:38218311 | Secisbp2l | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of SECISBP2L mRNA | CTD | PMID:25102026 | Secisbp2l | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:26496021|PMID:36041667 | Secisbp2l | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SECISBP2L mRNA | CTD | PMID:32145629 | Secisbp2l | Rat | bisphenol A | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SECISBP2L gene; [INS protein co-treated more ... | CTD | PMID:28628672|PMID:31601247 | Secisbp2l | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SECISBP2L mRNA | CTD | PMID:25181051 | Secisbp2l | Rat | bisphenol F | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Secisbp2l | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of more ... | CTD | PMID:36041667 | Secisbp2l | Rat | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of SECISBP2L mRNA | CTD | PMID:24136188 | Secisbp2l | Rat | Butylbenzyl phthalate | increases methylation | ISO | Secisbp2l (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of SECISBP2L intron | CTD | PMID:28392331 | Secisbp2l | Rat | cadmium dichloride | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Cadmium Chloride results in decreased expression of SECISBP2L mRNA | CTD | PMID:24982889 | Secisbp2l | Rat | caffeine | increases phosphorylation | ISO | SECISBP2L (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of SECISBP2L protein | CTD | PMID:35688186 | Secisbp2l | Rat | cisplatin | affects expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Cisplatin affects the expression of SECISBP2L mRNA | CTD | PMID:23300844 | Secisbp2l | Rat | cobalt dichloride | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of SECISBP2L mRNA | CTD | PMID:19376846 | Secisbp2l | Rat | copper(II) sulfate | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SECISBP2L mRNA | CTD | PMID:19549813 | Secisbp2l | Rat | coumarin | increases phosphorylation | ISO | SECISBP2L (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of SECISBP2L protein | CTD | PMID:35688186 | Secisbp2l | Rat | DDE | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of SECISBP2L mRNA | CTD | PMID:38568856 | Secisbp2l | Rat | dexamethasone | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Secisbp2l | Rat | Dibutyl phosphate | affects expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of SECISBP2L mRNA | CTD | PMID:37042841 | Secisbp2l | Rat | dioxygen | increases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of SECISBP2L mRNA | CTD | PMID:24205000 | Secisbp2l | Rat | diquat | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Diquat results in decreased expression of SECISBP2L protein | CTD | PMID:36851058 | Secisbp2l | Rat | doxorubicin | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SECISBP2L mRNA | CTD | PMID:29803840 | Secisbp2l | Rat | elemental selenium | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA | CTD | PMID:19244175 | Secisbp2l | Rat | elemental selenium | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Selenium results in decreased expression of SECISBP2L mRNA | CTD | PMID:19244175 | Secisbp2l | Rat | ethanol | affects splicing | ISO | Secisbp2l (Mus musculus) | 6480464 | Ethanol affects the splicing of SECISBP2L mRNA | CTD | PMID:30319688 | Secisbp2l | Rat | folic acid | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SECISBP2L mRNA | CTD | PMID:25629700 | Secisbp2l | Rat | formaldehyde | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of SECISBP2L mRNA | CTD | PMID:23649840 | Secisbp2l | Rat | fulvestrant | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SECISBP2L gene | CTD | PMID:31601247 | Secisbp2l | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SECISBP2L mRNA | CTD | PMID:33387578 | Secisbp2l | Rat | indometacin | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Secisbp2l | Rat | inulin | multiple interactions | ISO | Secisbp2l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SECISBP2L mRNA | CTD | PMID:36331819 | Secisbp2l | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SECISBP2L gene | CTD | PMID:35440735 | Secisbp2l | Rat | methyl methanesulfonate | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SECISBP2L mRNA | CTD | PMID:23649840 | Secisbp2l | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of SECISBP2L mRNA | CTD | PMID:24136188 | Secisbp2l | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SECISBP2L mRNA | CTD | PMID:33387578 | Secisbp2l | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SECISBP2L mRNA | CTD | PMID:27153767 | Secisbp2l | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Secisbp2l (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SECISBP2L mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Secisbp2l | Rat | phenobarbital | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of SECISBP2L mRNA | CTD | PMID:23091169 | Secisbp2l | Rat | pirinixic acid | increases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SECISBP2L mRNA | CTD | PMID:20813756|PMID:23811191 | Secisbp2l | Rat | rac-lactic acid | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SECISBP2L mRNA | CTD | PMID:30851411 | Secisbp2l | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SECISBP2L mRNA | CTD | PMID:28374803 | Secisbp2l | Rat | selenium atom | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA | CTD | PMID:19244175 | Secisbp2l | Rat | selenium atom | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Selenium results in decreased expression of SECISBP2L mRNA | CTD | PMID:19244175 | Secisbp2l | Rat | senecionine | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | senecionine results in decreased expression of SECISBP2L protein | CTD | PMID:35357534 | Secisbp2l | Rat | sodium arsenate | increases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | sodium arsenate results in increased expression of SECISBP2L mRNA | CTD | PMID:21795629 | Secisbp2l | Rat | sodium arsenite | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SECISBP2L mRNA | CTD | PMID:38568856 | Secisbp2l | Rat | sodium arsenite | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SECISBP2L mRNA | CTD | PMID:34032870 | Secisbp2l | Rat | sulforaphane | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | sulforaphane results in decreased expression of SECISBP2L mRNA | CTD | PMID:30529165 | Secisbp2l | Rat | thimerosal | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SECISBP2L mRNA | CTD | PMID:27188386 | Secisbp2l | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SECISBP2L mRNA | CTD | PMID:34492290 | Secisbp2l | Rat | thiram | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Thiram results in increased expression of SECISBP2L mRNA | CTD | PMID:38568856 | Secisbp2l | Rat | trichostatin A | affects expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | trichostatin A affects the expression of SECISBP2L mRNA | CTD | PMID:28542535 | Secisbp2l | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of SECISBP2L mRNA | CTD | PMID:30589522 | Secisbp2l | Rat | triphenyl phosphate | affects expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SECISBP2L mRNA | CTD | PMID:37042841 | Secisbp2l | Rat | tungsten | decreases expression | ISO | Secisbp2l (Mus musculus) | 6480464 | Tungsten results in decreased expression of SECISBP2L mRNA | CTD | PMID:30912803 | Secisbp2l | Rat | urethane | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Urethane results in increased expression of SECISBP2L mRNA | CTD | PMID:28818685 | Secisbp2l | Rat | valproic acid | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SECISBP2L mRNA | CTD | PMID:23179753 | Secisbp2l | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of SECISBP2L mRNA | CTD | PMID:29427782 | Secisbp2l | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of SECISBP2L mRNA | CTD | PMID:19015723 | Secisbp2l | Rat | vitamin E | multiple interactions | ISO | SECISBP2L (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA | CTD | PMID:19244175 | Secisbp2l | Rat | vorinostat | decreases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SECISBP2L mRNA | CTD | PMID:27188386 | Secisbp2l | Rat | zoledronic acid | increases expression | ISO | SECISBP2L (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of SECISBP2L mRNA | CTD | PMID:20977926 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















